Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (10)

2021

  1. Therapeutic drug monitoring of voriconazole: Validation of a high performance liquid chromatography method and comparison with an ARK immunoassay

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 3, pp. 154-159

2020

  1. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?

    Journal of Chemotherapy, pp. 1-13

2019

  1. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment

    Head and Neck, Vol. 41, Núm. 8, pp. 2704-2715

  2. Therapeutic approach in fungal keratitis

    Mycotic Keratitis (CRC Press), pp. 189-216

2018

  1. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model

    International Journal of Pharmaceutics, Vol. 549, Núm. 1-2, pp. 335-342

  2. Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis

    Pharmaceutics, Vol. 10, Núm. 2

2017

  1. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209

  2. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  3. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

2015

  1. In vitro and in vivo ocular safety and eye surface permanence determination by direct and Magnetic Resonance Imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 94, pp. 342-351